Stage I-IIA non-bulky Hodgkin's lymphoma. Is further distinction based on prognostic factors useful? The Stanford experience.
Advani
Ranjana H
RH
Department of Medicine, Division of Medical Oncology, Stanford University Medical Center, Stanford, California 94305, USA. radvani@stanford.edu
Hoppe
Richard T
RT
Maeda
Lauren S
LS
Baer
David M
DM
Mason
Joseph
J
Rosenberg
Saul A
SA
Horning
Sandra J
SJ